Posted by Michael Wonder on 28 Dec 2018
Life-prolonging drug for rare cancer sufferers to be made more affordable with PBS listing
28 December 2018 - A life-prolonging medicine for sufferers of a rare lung cancer is to be made available for no more than $40 a script from next year.
Each year, just 50 to 60 Australians — typically younger people and non-smokers — are diagnosed with the advanced metastatic non-small cell lung cancer.
Until now, sufferers have had to fork out about $7000 a month for oral doses of the drug, Xalkori, which is also known as crizotinib.
